You searched for "education"
Tough gig
1 December 2022
‘The times they are a-changin’. The words of this Dylan classic resonate down the decades, and in the light of recent events, speak eloquently to life in 2022. It feels like a lifetime of change has passed since the Eye...
My top five: A foundation doctor’s top five misconceptions about ophthalmology
4 December 2023
| Carina Mouritsen Luxhoj
|
EYE - General
Choosing a specialty is challenging. As a foundation doctor, it often feels as if this choice is based solely on fleeting experiences. Compared to other specialties, there is relatively little exposure to ophthalmology during either medical school or foundation years....
My Top Five: A foundation doctor’s top five misconceptions about ophthalmology
4 December 2023
| Carina Mouritsen Luxhoj
|
EYE - General
Choosing a specialty is challenging. As a foundation doctor, it often feels as if this choice is based solely on fleeting experiences. Compared to other specialties, there is relatively little exposure to ophthalmology during either medical school or foundation years....
Beyond ‘Shield and Ship’: a novel device (Eye-Aid) to provide temporary aqueous tamponade
4 February 2025
| Ben Smith
|
EYE - Cornea
The authors present a pilot efficacy study of the novel Eye-Aid device in a porcine model of full-thickness corneal wounds to mitigate anterior chamber collapse in the forward military environment. Currently, the ‘Shield and Ship’ paradigm taught to military healthcare...
Confocal microscopy and corneal graft rejection
Forty-five patients following penetrating keratoplasty (PK) were examined with the HRT III Rostock Cornea Module confocal microscope at various points after their surgery for two years. Activated keratocytes (AKs) were counted manually and their mean number evaluated. A pattern was...See sweet to C-suite: Peter Holland
4 December 2024
| David Lockington
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
See also - See sweet to C-suite: Imran Rahman In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part One: David speaks...
The fragile p-value
5 October 2020
| Abdus Samad Ansari
|
EYE - General
Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...
The last three patients: general practice (Patient One)
3 April 2023
| Jonathan Rees (Prof)
|
EYE - General
Professor Jonathan Rees is an Emeritus Professor of Dermatology at the University of Edinburgh (2020). He held the Grant Chair of Dermatology in Edinburgh from 2000 to 2020, and before that the Chair of Dermatology in Newcastle from 1992 to...
Conjunctival inflammation in glaucoma patients
1 April 2015
| Khadijah Basheer
|
EYE - Glaucoma
Numerous studies have demonstrated that topical medications and preservatives used for the management of glaucoma can induce significant histopathologic and inflammatory changes in the ocular surface. This study describes an increased expression of major histocompatibility complex class II antigen HLA-DR,...
‘At risk’ corneas are more easily identified with SCORE
Risk assessment of post-LASIK corneal ectasia in refractive surgery patients is now a more exact, objective, evaluation thanks to the work of Heidelberg Engineering and a leading research partner in Paris.
New mouse model of diabetes mellitus
1 April 2014
| Graham Wallace
|
EYE - Vitreo-Retinal
Diabetic retinopathy (DR) is a serious complication of diabetes. It is driven by the loss of pericytes, cells which control vascular function, due to excess formation of sugar alcohols by the enzyme aldose reductase (AR). AR has been shown to...
Intravitreal aflibercept for retinal angiomatous proliferation (RAP)
2 December 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this prospective study the authors present the visual and anatomical outcome of patients with RAP lesions who were treated with intravitreal aflibercept. The study cohort of 46 patients reached study completion at week 96. They were all Caucasians, with...
